Target
Bromodomain-containing protein 9 [134-239]
Ligand
BDBM321402
Substrate
n/a
Meas. Tech.
IC50 measurements for inhibitors using BRD9 AlphaLisa Binding Assay
IC50
17.0±n/a nM
Citation
 Albrecht, BKBellon, SFBurdick, DJCote, ACrawford, TDakin, LAHsiao-Wei Tsui, VHewitt, MCLeBlanc, YMagnuson, SRNasveschuk, CGRomero, FATang, YTaylor, AMWang, S Therapeutic compounds and uses thereof US Patent  US10183009 Publication Date 1/22/2019 
Target
Name:
Bromodomain-containing protein 9 [134-239]
Synonyms:
BRD9 | BRD9 (aa 134-239) | BRD9_HUMAN
Type:
Enzyme Catalytic Domain
Mol. Mass.:
12286.22
Organism:
Homo sapiens (Human)
Description:
Q9H8M2[134-239]
Residue:
106
Sequence:
AENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSK
  
Inhibitor
Name:
BDBM321402
Synonyms:
6-[(E)-but-2-enyl]-4-[4-(1-hydroxy-1-methyl-ethyl)phenyl]-1H-pyrrolo[2,3-c]pyridin-7-one | US10183009, Example 81
Type:
Small organic molecule
Emp. Form.:
C20H22N2O2
Mol. Mass.:
322.4009
SMILES:
C\C=C\Cn1cc(-c2ccc(cc2)C(C)(C)O)c2cc[nH]c2c1=O
Structure:
Search PDB for entries with ligand similarity: